Australia markets close in 2 hours 27 minutes

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.23-0.77 (-5.50%)
At close: 04:00PM EDT
13.25 +0.02 (+0.15%)
After hours: 06:23PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. Estimate-1.33-1.23-5.09-4.67
Low estimate-1.63-1.65-6.55-6.69
High estimate-1.11-0.91-4.35-3.35
Year ago EPS-1.79-1.86-6.38-5.09
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7767
Avg. Estimate16.52M16.88M67.82M74.92M
Low estimate14M14M59M50M
High estimate18M20M72.6M111.94M
Year ago salesN/AN/A79.2M67.82M
Sales growth (year/est)N/AN/A-14.40%10.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.98-2.34-2.15-1.19
Actual EPS-1.79-1.86-1.33-1.58
Difference0.190.480.82-0.39
Surprise %9.60%20.50%38.10%-32.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.33-1.23-5.09-4.67
7 days ago-1.33-1.23-5.09-4.67
30 days ago-1.33-1.23-5.09-4.67
60 days ago-1.35-1.22-5.22-4.89
90 days ago-1.24-1.12-5.15-4.71
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesENTAIndustrySector(s)S&P 500
Current qtr.25.70%N/AN/AN/A
Next qtr.33.90%N/AN/AN/A
Current year20.20%N/AN/AN/A
Next year8.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)-10.60%N/AN/AN/A